JP2009520018A5 - - Google Patents

Download PDF

Info

Publication number
JP2009520018A5
JP2009520018A5 JP2008546664A JP2008546664A JP2009520018A5 JP 2009520018 A5 JP2009520018 A5 JP 2009520018A5 JP 2008546664 A JP2008546664 A JP 2008546664A JP 2008546664 A JP2008546664 A JP 2008546664A JP 2009520018 A5 JP2009520018 A5 JP 2009520018A5
Authority
JP
Japan
Prior art keywords
phenyl
pharmaceutically acceptable
group
acceptable salt
ylmethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008546664A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009520018A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2006/003639 external-priority patent/WO2007072150A2/en
Publication of JP2009520018A publication Critical patent/JP2009520018A/ja
Publication of JP2009520018A5 publication Critical patent/JP2009520018A5/ja
Withdrawn legal-status Critical Current

Links

JP2008546664A 2005-12-20 2006-12-16 ピペリジン誘導体 Withdrawn JP2009520018A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75184505P 2005-12-20 2005-12-20
PCT/IB2006/003639 WO2007072150A2 (en) 2005-12-20 2006-12-16 Piperidine derivatives

Publications (2)

Publication Number Publication Date
JP2009520018A JP2009520018A (ja) 2009-05-21
JP2009520018A5 true JP2009520018A5 (enExample) 2009-12-03

Family

ID=38015373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008546664A Withdrawn JP2009520018A (ja) 2005-12-20 2006-12-16 ピペリジン誘導体

Country Status (12)

Country Link
US (1) US20070142389A1 (enExample)
EP (1) EP1966137A2 (enExample)
JP (1) JP2009520018A (enExample)
AR (1) AR058110A1 (enExample)
CA (1) CA2634172A1 (enExample)
DO (1) DOP2006000287A (enExample)
GT (1) GT200600516A (enExample)
NL (2) NL2000376C2 (enExample)
PE (1) PE20071005A1 (enExample)
TW (1) TW200732304A (enExample)
UY (1) UY30029A1 (enExample)
WO (1) WO2007072150A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010059390A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Modulators of serotonin receptor
US8642583B2 (en) 2008-10-30 2014-02-04 Janssen Pharmaceutica Nv Serotonin receptor modulators
DK2358676T3 (da) 2008-11-14 2013-01-14 Theravance Inc Krystallinsk form af en 4-[2-(2-fluorphenoxymethyl)phenyl]-piperidinforbindelse
JP5705239B2 (ja) 2010-01-11 2015-04-22 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー セロトニンおよびノルエピネフリン再取込みインヒビターとしての1−(2−フェノキシメチルフェニル)ピペラジン化合物
TW201334783A (zh) * 2012-01-31 2013-09-01 Eisai R&D Man Co Ltd 帕羅西汀(Paroxetine)衍生物
EP3344248B1 (en) * 2015-09-02 2022-03-23 Trevena, Inc. 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CA3052480A1 (en) 2017-02-17 2018-08-23 Trevena, Inc. 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CN110446495B (zh) 2017-02-17 2023-09-05 特维娜有限公司 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
CN111533682B (zh) * 2020-05-29 2022-03-01 清华大学 帕罗西汀及其类似物的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
IE45511B1 (en) * 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
EP0190496A3 (en) * 1984-12-13 1987-05-27 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
US5227379A (en) * 1986-11-03 1993-07-13 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
DK231088D0 (da) * 1988-04-28 1988-04-28 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
IL98757A (en) * 1990-07-18 1997-01-10 Novo Nordisk As Piperidine derivatives their preparation and pharmaceutical compositions containing them
US5808139A (en) * 1992-04-21 1998-09-15 Ligand Pharmaceuticals Incorporated Non-steroid progesterone receptor agonist and antagonist and compounds and methods
US5914328A (en) * 1992-10-09 1999-06-22 Abbott Laboratories Heterocyclic ether compounds useful in controlling neurotransmitter release
IL123293A (en) * 1995-09-07 2003-06-24 Hoffmann La Roche Piperidine derivatives, their preparation and pharmaceutical compositions containing them
US20020151712A1 (en) * 1999-09-14 2002-10-17 Nan-Horng Lin 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
AU1018801A (en) * 1999-10-29 2001-05-14 Novo Nordisk A/S Use of 3,4-substituted piperidines
US20040087795A1 (en) * 2000-07-17 2004-05-06 Borrett Gary Thomas Novel processes for the preparation of 4-phenylpiperidine derivatives
US20040235906A1 (en) * 2001-08-08 2004-11-25 Gouliaev Alex Haahr Substituted amine derivatives and their use as monoamine neurotransmitter re-up-take inhibitors

Similar Documents

Publication Publication Date Title
JP2013542218A5 (enExample)
JP2006508913A5 (enExample)
JP2008525417A5 (enExample)
JP2010509356A5 (enExample)
JP2013509392A5 (enExample)
JP2014037426A5 (enExample)
JP2013505969A5 (enExample)
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
JP2018519323A5 (enExample)
JP2014521744A5 (enExample)
JP2013507425A5 (enExample)
RU2006100190A (ru) Производные хинолиламида в качестве антагонистов ccr-5
JP2011519854A5 (enExample)
RU2007119378A (ru) Твердый состав с улучшенными растворимостью и стабильностью и способ его получения
JP2007517035A5 (enExample)
JP2008530099A5 (enExample)
JP2009535362A5 (enExample)
JP2010155827A5 (enExample)
JP2006523193A5 (enExample)
JP2013508382A5 (enExample)
JP2008517913A5 (enExample)
JP2010501478A5 (enExample)
JP2011526584A5 (enExample)
RU95117585A (ru) ПРОИЗВОДНЫЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ
JP2009520018A5 (enExample)